Idt Australia Ltd has released a press release.
Thiotepa - Contract Extension and Revenues
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from IDT Australia
- $6m Placement to Accelerate IDTs Generic Drug Portfolio
- IDT Executes US Distribution Agreement for Temozolomide
Later from IDT Australia
- Manufacturing partner appointed
- Reinstatement to Official Quotation
- FDA Approval for Temozolomide
- CMAX - Opening of new Clinical Trial Facility
- Completion of private placement
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia